Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.
about
Thiopurine monitoring in children with inflammatory bowel disease: a systematic reviewMedical management of Crohn's disease: current therapy and recent advances.Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.How to do without steroids in inflammatory bowel disease.Monitoring thiopurine metabolites in korean pediatric patients with inflammatory bowel diseaseReview article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.Clinical aspects and pathophysiology of inflammatory bowel disease.Review article: acute severe ulcerative colitis - evidence-based consensus statements.The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.Review article: monitoring for drug side-effects in inflammatory bowel disease.Treatment of inflammatory bowel disease in childhood: best available evidence.Current therapy of ulcerative colitis in children.Safety Profile of Thiopurines in Crohn Disease: Analysis of 893 Patient-Years Follow-Up in a Southern China CohortOptimizing therapy in patients with pancolitis.Managing complicated Crohn's disease in children and adolescents.Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease.Review article: thiopurines in inflammatory bowel disease.Update in the treatment of paediatric ulcerative colitis.Thiopurines in inflammatory bowel disease revisitedMonitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesInfliximab therapy for pediatric Crohn's disease.Specific considerations in the treatment of pediatric inflammatory bowel disease.Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine.Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.Thiopurines in Crohn's disease, is there something new?Pediatric ulcerative colitis: current treatment approaches including role of infliximab.Approach to a Child with Colitis.The safety of treatment options for pediatric Crohn's disease.Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.Long term results of use of azathioprine in patients with ulcerative colitis in India.A very high amylase can be benign in paediatric Crohn's disease.Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta-analysis.Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab.Adverse events associated with azathioprine treatment in korean pediatric inflammatory bowel disease patients.Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration.Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts.An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis.Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.
P2860
Q26859122-B4A93129-47C2-4B0C-92DA-4C0EDDF9BEB3Q30450875-E453C941-839B-4EB9-BC96-12C63A61769EQ30687155-D3FCFB7C-88BA-4A86-A019-6208BE6112EFQ33853564-F2B3C7DC-DA68-4E14-AC0F-3A3E18A15BDCQ33941619-39F0280B-6F1F-4F2A-A3FC-6F3C584D2A1FQ34421471-44C55E84-FF16-4A39-93A4-7F5DD80F4434Q34487217-A0BA4208-F91E-4B21-9D18-4CC4B9D6CBF6Q34528270-A0C97A66-4134-40F4-9BC8-7DE399C1C721Q34559065-8178F683-0B7E-4861-9D56-F71CB5F02997Q34560319-26296223-D50E-4A41-9CC3-B35C740CB2E8Q34585315-11EC02F6-F8E7-4954-B41F-9CA8C77D7438Q35091746-EC91784F-61CA-4B9A-9C88-540605351CAFQ35609674-CA43056A-5E54-4ACA-B456-1F9A64E1B1FFQ36195577-80A04C1F-7B10-4322-AAC6-4C828AA4DCF9Q36270395-BB115A51-70DE-49C6-9E98-670EE855F3D1Q36331225-6FA1E81C-5D58-425A-8E4D-3D0D0C54FFADQ36521192-6B33EE9D-FA71-458D-88D7-78A68F207F7BQ36570796-E6203F87-D968-481A-8E41-6D67E64985A3Q36613876-B8214686-D5BF-46ED-91BE-DC677E678EE5Q36715034-49831BD7-7C97-4851-9C3D-973375FAC4E1Q36724093-B4C9599C-CC6D-4994-A8D4-3B1D65DB27AFQ37012073-DB3C4768-B326-4730-8B0D-5D84467E9E80Q37345918-EC026C35-607F-446E-B6F0-7590654D691AQ37724360-90B9A44F-193A-4AE0-BFDE-6B9587540BBEQ37769253-5438B3BB-70C9-488E-9C0C-8D2F838ECCBCQ37797517-C8992CD0-DD13-410D-A9E5-D07E2BA60F6AQ38022238-C484969A-A793-4515-8999-BCF114871804Q38808872-DF8D820C-7407-4D7D-A991-D2EE6DBB3F41Q38883237-74BF15A8-204A-4CFF-80FD-CB902C13979CQ39684886-6335B37F-903A-4FFE-B3E5-240CC8BE30EDQ41824164-93C272BA-9BEB-4C2F-8C40-51B2D869749AQ42078956-63F5E958-7AE0-4A96-AA5B-8721E96315F4Q42361938-73D7B744-CA46-432C-9743-861041CC0E8EQ42775426-6724BA22-CBF4-48C9-A2EB-FAD4954CD45EQ42919311-ACD32B65-2678-4E9D-91A4-75785B9365B7Q43159235-0F04191F-3C11-4A54-BDBD-388BD8CEC5C8Q43162040-38F4DFC0-6F0D-48CE-A264-646E4B4B7888Q43714765-CB4899D5-A66F-4906-B717-76A69F6C9E6BQ43734542-8CC16540-14E2-4E4A-86FD-B443BDC84197Q43749263-2A8CEA35-B2AD-466B-99A9-332CBED584EE
P2860
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@ast
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@en
type
label
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@ast
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@en
prefLabel
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@ast
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@en
P1433
P1476
Safety of azathioprine and 6-m ...... th inflammatory bowel disease.
@en
P2093
Kirschner BS
P304
P356
10.1016/S0016-5085(98)70251-3
P407
P577
1998-10-01T00:00:00Z